Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/15/2015 | WO2015003675A1 Method for quantitative characterization of substances for their binding to amyloid-ss (ass) conformers |
01/15/2015 | WO2015003674A2 Method for the quantitative characterisation of amyloid and/or aggregating peptides and/or proteins in a sample |
01/15/2015 | WO2015003531A1 Method for identifying species using molecular weights of nucleic acid cleavage fragments |
01/15/2015 | WO2014170681A9 Oligosaccharide conjugates and methods of use |
01/15/2015 | US20150020221 Compositions and Methods for the Modulation of DNA Damage Responses Using BAL1 and BBAP |
01/15/2015 | US20150019170 Method and device for processing a time-dependent measurement signal |
01/15/2015 | US20150019142 Damage evaluation method and maintenance evaluation index decision method |
01/15/2015 | US20150019140 Dielectric spectroscopy methods and apparatus |
01/15/2015 | US20150019138 Systems and methods for determining ingredient amounts for preparations for administration to patients |
01/15/2015 | US20150019137 Bioinformation Processing Apparatus and Signal Processing Method |
01/15/2015 | US20150019133 Acoustic monitoring of block caving |
01/15/2015 | US20150018966 Decellularisation of tissue matrices for bladder implantation |
01/15/2015 | US20150018703 Capnography Module with Automatic Switching Between Mainstream and Sidestream Monitoring |
01/15/2015 | US20150018641 Fiber Optic Device for Sensing Analytes and Method of Making Same |
01/15/2015 | US20150018532 Antibody |
01/15/2015 | US20150018523 Unnatural reactive amino acid genetic code additions |
01/15/2015 | US20150018409 Chimeric polypeptides and their use |
01/15/2015 | US20150018406 Modulation of breast cancer growth by modulation of xbp1 activity |
01/15/2015 | US20150018389 Method for treating parkinsons disease and other neurological diseases |
01/15/2015 | US20150018383 Biomarkers of renal disorders |
01/15/2015 | US20150018380 Methods of Screening for Activation Deaminase Inhibitors Through Nuclear Import Inhibitors |
01/15/2015 | US20150018371 Positive allosteric modulators for melanocortin receptors |
01/15/2015 | US20150018323 3b-hydroxysteroid dehydrogenase in steroid-dependent disease |
01/15/2015 | US20150018285 ANTAGONISTS OF Bcl-2 AND USES THEREOF IN INDUCTION OF APOPTOSIS |
01/15/2015 | US20150018253 Methods and Compositions for Selective Labeling of Different Biotinylated Targets within Multicolor or Multilabel Assays |
01/15/2015 | US20150018251 Protein chips, preparation and use thereof |
01/15/2015 | US20150018250 Symmetrically Branched Polymer Conjugates and Microarray Assays |
01/15/2015 | US20150018248 Array plates for washing samples |
01/15/2015 | US20150018246 Polypeptide marker for diagnosing and assessing vascular diseases |
01/15/2015 | US20150018244 Means and methods for assessing hyperthyroidism |
01/15/2015 | US20150018241 Fc-receptor based affinity chromatography |
01/15/2015 | US20150018240 Theranostics platform and methods of use |
01/15/2015 | US20150018239 Biomarker set for identifying a severe form of cancer |
01/15/2015 | US20150018238 Multi-biomarker-based outcome risk stratification model for pediatric septic shock |
01/15/2015 | US20150018237 Means and methods for assessing bone disorders |
01/15/2015 | US20150018235 Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer |
01/15/2015 | US20150018234 Biomarkers for diagnosing ischemia |
01/15/2015 | US20150018233 Methods and g proteins for screening and identifying ligands of g protein-coupled receptors |
01/15/2015 | US20150018229 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
01/15/2015 | US20150018225 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for examining cancer |
01/15/2015 | US20150018224 Reagents and methods for detecting protein lysine 2-hydroxyisobutyrylation |
01/15/2015 | US20150018223 Methods of diagnosing tau-associated neurodegenerative diseases |
01/15/2015 | US20150017739 Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers |
01/15/2015 | US20150017738 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
01/15/2015 | US20150017734 Quality control marker and its use in herbs authentication |
01/15/2015 | US20150017733 Method and Device for Monitoring Medication Usage |
01/15/2015 | US20150017732 Colorimetric method to detect illicit drugs |
01/15/2015 | US20150017731 Test apparatus and method of accelerated photo-degradation using plasma light source |
01/15/2015 | US20150017730 Urea solution quality determining system |
01/15/2015 | US20150017684 Streptococcus pyogenes antigens and corresponding dna fragments |
01/15/2015 | US20150017681 Device and method for biological sample collection and inspection |
01/15/2015 | US20150017677 Cancer stem cells |
01/15/2015 | US20150017676 Capsules containing mammalian cells |
01/15/2015 | US20150017675 Assay for determining relative redox changes in living cells and associated devices, systems, and methods |
01/15/2015 | US20150017674 Method for differentiation of pluripotent stem cells into vascular bed cells |
01/15/2015 | US20150017673 Compositions and methods for drug-sensitization or inhibition of a cancer cell |
01/15/2015 | US20150017669 Process and its application for improving reproducibility in maldi-tof glycan profiling of human serum: experimental procedure and application to the screening for ovarian tumors |
01/15/2015 | US20150017668 Methods and compositions for diagnosing and treating mood disorders |
01/15/2015 | US20150017667 Means and methods for assessing liver disorders |
01/15/2015 | US20150017666 Diagnostic peptides for lyme disease |
01/15/2015 | US20150017665 Peptides and Methods for Detecting MPO-ANCA |
01/15/2015 | US20150017664 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same |
01/15/2015 | US20150017663 Identification of antitumor compounds using placenta |
01/15/2015 | US20150017662 Method for detecting and quantifying a target protein or a target cell using an aptamer chip |
01/15/2015 | US20150017661 Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject |
01/15/2015 | US20150017660 Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome |
01/15/2015 | US20150017659 Profiling of signal pathway proteins to determine therapeutic efficacy |
01/15/2015 | US20150017658 Stain, process for staining and acquiring normalized signal |
01/15/2015 | US20150017657 Assay and method for identifying compounds that inhibit excitotoxic signals |
01/15/2015 | US20150017656 Rapid Lateral Flow Assay Method for Detecting Low Quantity Liquid or Dry Samples |
01/15/2015 | US20150017651 Personalized medicine for the prediction of therapy targeting the hedgehog pathway |
01/15/2015 | US20150017641 Mechanical Washing and Measuring Device for Performing Analyses |
01/15/2015 | US20150017639 Molecular Diagnostic Assay Device And Method Of Use |
01/15/2015 | US20150017638 Methods for assessing risk for cancer using biomarkers |
01/15/2015 | US20150017637 Recurrent gene fusions in cancer |
01/15/2015 | US20150017633 Methods and compositions to evaluate antibody treatment response |
01/15/2015 | US20150017630 Signatures and determinants for diagnosing infections and methods of use thereof |
01/15/2015 | US20150017258 Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays & versatile and green methods for synthesis of anisotropic silver nanostructures |
01/15/2015 | US20150017230 ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
01/15/2015 | US20150017210 Gene Signature Predicts Adenocarcinoma Prognosis and Therapeutic Response |
01/15/2015 | US20150017202 Synthetic toll-like receptor-4 (tlr-4) agonist peptides |
01/15/2015 | US20150017200 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
01/15/2015 | US20150017173 Antibodies to human transmembrane proteins |
01/15/2015 | US20150017153 Monoclonal antibodies that neutralize anthrax toxins |
01/15/2015 | US20150017134 Emt-inducing transcription factors cooperate with sox9 |
01/15/2015 | US20150017133 Phenotype profile of human retinal progenitor cells |
01/15/2015 | US20150017119 Methods for diagnosis, prognosis and methods of treatment |
01/15/2015 | US20150017099 Diagnosis and treatment for respiratory tract diseases |
01/15/2015 | US20150017095 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof |
01/15/2015 | US20150017092 Devices and methods for determining sensitivity to radiation |
01/15/2015 | US20150017091 Detection and treatment of metastatic disease |
01/15/2015 | US20150017068 Improved electronic analyte assaying device |
01/15/2015 | US20150017067 Micro-sensor based test apparatus |
01/15/2015 | US20150017066 Line immunoassay testing device |
01/15/2015 | US20150017065 System for determining biofuel concentration |
01/15/2015 | US20150016486 Remote electromigration monitoring of electronic chips |
01/15/2015 | US20150015886 Method for the evaluation of the colloidal stability of liquid biopolymer solutions |
01/15/2015 | US20150015881 Gas concentration estimation device |
01/15/2015 | US20150015878 Raman spectroscopic analyzing apparatus |
01/15/2015 | US20150015877 Gemstone inspection |